A detailed history of Wolverine Trading, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 13,198 shares of APLS stock, worth $439,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,198
Previous 9,216 43.21%
Holding current value
$439,757
Previous $353,000 7.65%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$28.84 - $41.15 $114,840 - $163,859
3,982 Added 43.21%
13,198 $380,000
Q2 2024

Aug 14, 2024

SELL
$38.07 - $59.71 $117,331 - $184,026
-3,082 Reduced 25.06%
9,216 $353,000
Q1 2024

May 15, 2024

BUY
$55.39 - $72.47 $309,020 - $404,310
5,579 Added 83.03%
12,298 $722,000
Q4 2023

Feb 14, 2024

SELL
$37.14 - $64.82 $581,426 - $1.01 Million
-15,655 Reduced 69.97%
6,719 $402,000
Q3 2023

Nov 15, 2023

BUY
$23.65 - $89.22 $529,145 - $2 Million
22,374 New
22,374 $851,000
Q1 2023

May 15, 2023

BUY
$46.59 - $66.96 $277,955 - $399,483
5,966 New
5,966 $394,000
Q3 2021

Nov 12, 2021

BUY
$31.4 - $69.84 $1.04 Million - $2.31 Million
33,143 New
33,143 $1.13 Million

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.66B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.